Multiple myeloma survivor seeks to empower patients by illustrating the value of human life.
Hematology
Latest News
Advertisement
CME Content
Advertisement
Protein determines whether breast cancer cells become resistant to tamoxifen.
The activation of the STAT5 protein linked to acute lymphoblastic leukemia.
Polymer capsules that could play a key role in delivering targeted cancer therapies.
Top news of the week in oncology and cancer drug development.
Top news of the week in oncology and cancer drug development.
Hodgkin lymphoma cancer survivors are 2.4 times more likely to develop a second type of cancer.
Study identifies potential Achilles heel of kinase-driven cancers.
Treatment with endostatin slowed the proliferation of resistant prostate cancer cells.
Most models were cancer-free within 6 weeks of treatment with selenomab-drug conjugates.
Next-generation antibody treatments effectively deliver cytotoxic drugs to tumors.
Corticosteroids, chemotherapy, and immunotherapy may all be used to treat castration-resistant prostate cancer.
Top news of the week in oncology and cancer drug development.
Checkpoint inhibitors plus myeloid-derived suppressor cell inhibitors show promise as prostate cancer treatment.
Quiescent stem cells are dormant and are not impacted by cancer treatments.
The addition of abemaciclib to fulvestrant appeared to effectively improve progression-free survival in patients with breast cancer.
The addition of abemaciclib to fulvestrant appeared to effectively improve progression-free survival.
High yogurt intake may protect against breast cancer, while processed cheeses may increase cancer risk.
Mapping lung cancer cell interactions can unveil new targeted treatment techniques.
Vitamin C observed to kill cancer stem-like cells.
Nanomachines produce a florescent response when in contact with cancer biomarkers.
Muscle composition may be predictive of chemotherapy toxicity.
Clinical practice guideline on human papillomavirus (HPV) vaccination can improve prevention of cervical cancer.
The risk of a second cancer remained high even 30 years after treatment.
Top news of the week in oncology and cancer drug development.
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Adults With Schizophrenia Remain Stable When Transitioning from Atypical Antipsychotic to Cobenfy
4
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
5